Tecogen
Tecogen's revenue rose 19.7% to $27 million in fiscal 2025. Its operating margin was −30.4%, down from −20.1% a year earlier. Free cash flow was −$10 million, against $3 million a year earlier. The diluted share count rose 9.5%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Income statement
Tecogen lost money in fiscal 2025: a net loss of $8 million.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 4 | 2 | 1 | 5 | 12 |
| Debt incl. finance leases | 0 | 0 | 0 | 0 | 1 |
| Net debt (negative means net cash) | −4 | −2 | −1 | −5 | −11 |
| Net debt to EBITDA | — | — | — | — | — |
| Debt to equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.1x |
| Interest coverage | −85.6x | −144.5x | −275.0x | −50.2x | −54.9x |
| Current ratio | 2.8x | 2.9x | 1.9x | 1.3x | 3.1x |
| Quick ratio | 2.0x | 1.5x | 0.9x | 0.7x | 1.9x |
Cash flow
Projections
Project Tecogen's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, 6 insiders bought $191,255 of Tecogen shares on the open market, and none sold any.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 18, 2026 | Roger P. DeschenesChief Financial Officer | Bought | 10,000 | $1.80 | $17,997 | Form 4 |
| Nov 16, 2026 | John Kimball Whiting IVGeneral Counsel & Secretary | Bought | 10,000 | $1.96 | $19,600 | Form 4 |
| Nov 16, 2026 | Earl LewisDirector | Bought | 10,000 | $1.96 | $19,557 | Form 4 |
| Apr 24, 2026 | Ahmed GhoniemDirector | Bought | 12,723 | $0.79 | $10,051 | Form 4 |
| Apr 13, 2026 | Susan B HirschDirector | Bought | 5,000 | $3.73 | $18,650 | Form 4 |
| Mar 27, 2026 | Susan B HirschDirector | Bought | 10,000 | $2.54 | $25,400 | Form 4 |
| Mar 27, 2026 | Earl LewisDirector | Bought | 5,000 | $2.52 | $12,600 | Form 4 |
| Mar 26, 2026 | Earl LewisDirector | Bought | 5,000 | $2.88 | $14,400 | Form 4 |
| Mar 23, 2026 | John Kimball Whiting IVGeneral Counsel & Secretary | Bought | 10,000 | $2.38 | $23,800 | Form 4 |
| Mar 20, 2026 | Roger P. DeschenesCAO | Bought | 10,000 | $2.23 | $22,300 | Form 4 |
| Mar 20, 2026 | Abinand RangeshChief Executive Officer, Director | Bought | 3,000 | $2.30 | $6,900 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 3 of 9 | 3 of 9 | 2 of 9 |
| Rule of 40 | −2.9% | 3.6% | −18.4% |
| Altman Z'' | −2.61 | −4.34 | −1.49 |
| Accruals ratio | −13.5% | −30.0% | 4.9% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Fail | Fail | Fail |
| Cash from operations is positive | Fail | Pass | Fail |
| Return on assets rose | Fail | Fail | Fail |
| Cash from operations exceeds net income | Pass | Pass | Fail |
| Debt fell relative to assets | Fail | Fail | Fail |
| Current ratio rose | Fail | Fail | Pass |
| Share count didn't rise | Pass | Fail | Fail |
| Gross margin rose | Fail | Pass | Fail |
| Revenue rose relative to assets | Pass | Fail | Pass |
| F-score | 3 of 9 | 3 of 9 | 2 of 9 |
Compare
Put Tecogen side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Tecogen | FY25 | 19.7% | −30.4% | −38.1% | −84.3% | — | 2 | |
| Fuel Tech | FY25 | 6.1% | −13.8% | 8.8% | −15.2% | — | 5 | Compare |
| Chicago Rivet & Machine | FY25 | 3.4% | −4.3% | −5.6% | −5.4% | −82.1x | 4 | Compare |
| TechPrecision | FY26 | −7.0% | −3.4% | −10.3% | −5.6% | 3.7x | 6 | Compare |
| Luda Technology Group | FY25 | −25.2% | −3.2% | −6.5% | −2.5% | — | 3 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 24 | 33 | 36 | 33 | 28 | 24 | 25 | 25 | 23 | 27 |
| Revenue growth | 14.2% | 35.6% | 8.1% | −6.8% | −15.5% | −13.7% | 2.5% | 0.6% | −10.0% | 19.7% |
| Gross profit | 9 | 13 | 14 | 12 | 11 | 12 | 11 | 10 | 10 | 10 |
| Research and development | 1 | 1 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 1 |
| Operating income | −1 | 0 | −6 | −5 | −6 | −1 | −2 | −4 | −4 | −8 |
| Net income | −1 | 0 | −6 | −5 | −6 | 4 | −2 | −5 | −5 | −8 |
| Diluted EPS (US$) | −0.06 | 0.00 | −0.23 | −0.19 | −0.25 | 0.15 | −0.10 | −0.19 | −0.19 | −0.30 |
| Diluted shares (millions) | 19 | 23 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 27 |
| Cash flow | ||||||||||
| Cash from operations | −3 | −1 | −4 | −4 | 1 | 0 | −1 | −1 | 4 | −10 |
| Capital expenditure | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Free cash flow | −3 | −1 | −5 | −5 | 1 | 0 | −2 | −1 | 3 | −10 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 4 | 2 | 0 | 1 | 2 | 4 | 2 | 1 | 5 | 12 |
| Debt incl. finance leases | — | — | — | 0 | 2 | 0 | 0 | 0 | 0 | 1 |
| Total assets | 24 | 51 | 50 | 41 | 30 | 32 | 28 | 28 | 31 | 37 |
| Total liabilities | 9 | 17 | 22 | 18 | 13 | 11 | 9 | 13 | 21 | 16 |
| Shareholders' equity | 14 | 33 | 28 | 23 | 17 | 21 | 19 | 15 | 10 | 22 |
| Margins and ratios | ||||||||||
| Gross margin | 38.0% | 39.0% | 37.9% | 37.3% | 38.3% | 47.5% | 44.3% | 40.6% | 43.6% | 36.3% |
| Operating margin | −4.1% | 0.7% | −15.4% | −13.9% | −21.1% | −5.0% | −9.4% | −17.6% | −20.1% | −30.4% |
| Net margin | −4.5% | 0.1% | −15.9% | −14.1% | −21.8% | 15.2% | −9.8% | −18.3% | −21.0% | −30.5% |
| Free cash flow margin | −11.7% | −3.5% | −13.1% | −13.7% | 4.8% | 1.5% | −6.7% | −3.4% | 13.7% | −38.1% |
| Rule of 40 (growth + FCF margin) | 2.5% | 32.0% | −5.0% | −20.6% | −10.7% | −12.1% | −4.2% | −2.9% | 3.6% | −18.4% |
| Return on capital | — | — | — | — | −23.5% | −6.9% | −10.7% | −22.8% | −38.5% | −84.3% |
| Return on equity | −8.0% | 0.2% | −18.7% | −18.4% | −30.3% | 19.2% | −12.2% | −27.2% | −38.1% | −51.8% |
| Return on assets | −4.9% | 0.1% | −11.3% | −10.3% | −17.3% | 11.8% | −8.1% | −16.4% | −16.2% | −24.2% |
| Net debt to EBITDA | — | — | — | — | — | — | — | — | — | — |